The global preimplantation genetic screening (PGS) technology market is experiencing transformative advancements in prenatal screening and diagnosis of chromosomal abnormalities. Cutting-edge technologies have revolutionized in vitro fertilization (IVF) processes by incorporating non-invasive cell-free fetal DNA-based detection and carrier screening panels into prenatal care. PGS technology emerges as a significant market driver, enabling early detection of congenital disorders during the initial stages of the IVF workflow. This facilitates the reduction of inherited chromosomal abnormalities in fetuses, underscoring the pivotal role of PGS in enhancing the success and safety of assisted reproduction.
According to Data Bridge Market Research, the Global Preimplantation Genetic Screening (PGS) Technology Market was USD 552.50 million in 2021, is expected to reach USD 1,228.09 million by 2029, and is expected to undergo a CAGR of 10.50% during the forecast period 2022 to 2029.
“Rising number of fertility clinics globally facilitate market growth”
The rising number of fertility clinics globally serves as a significant driver for the preimplantation genetic screening (PGS) technology market. As the demand for assisted reproductive technologies such as in vitro fertilization (IVF) continues to surge, the establishment of more fertility clinics becomes essential to accommodate this growing need. These clinics offer PGS as a valuable tool to enhance the success rates of IVF procedures by selecting genetically healthy embryos. This expansion of fertility clinics amplifies the adoption of PGS technology, fostering its market growth and accessibility for couples seeking successful pregnancies.
What restraints the growth of the global preimplantation genetic screening (PGS) technology market?
“High cost associated with preimplantation genetic screening (PGS) technology”
The high cost associated with preimplantation genetic screening (PGS) technology serves as a significant restraint in the global market. The intricate process of genetic screening involves advanced technologies and specialized expertise, resulting in substantial expenses for couples seeking these services. The elevated costs can create a barrier for many individuals, limiting their access to PGS procedures. This financial challenge can deter potential beneficiaries from pursuing PGS, thereby impeding the broader adoption of this technology and hindering its realization of its full potential in improving assisted reproductive outcomes.
Segmentation: Global Preimplantation Genetic Screening (PGS) Technology Market
The preimplantation genetic screening (PGS) technology market is segmented on the basis of procedure type, technology, product and services, test type, application, and end user.
- On the basis of procedure type, the preimplantation genetic screening (PGS) technology market is segmented into preimplantation genetic screening, and preimplantation genetic diagnosis.
- On the basis of technology, the preimplantation genetic screening (PGS) technology market is segmented into next-generation sequencing, polymerase chain reaction, fluorescence in situ hybridization, comparative genomic hybridization, and single-nucleotide polymorphism.
- On the basis of product and services, the preimplantation genetic screening (PGS) technology market is segmented into reagents and consumables, instruments, software, and services.
- On the basis of end user, the preimplantation genetic screening (PGS) technology market is segmented into maternity centers and fertility clinics, hospitals, diagnostic labs, service providers, research laboratories, and academic institutes.
- On the basis of test type, the preimplantation genetic screening (PGS) technology market is segmented into chromosomal abnormalities, x-linked diseases, embryo testing, aneuploidy screening, HLA typing, and other PGT types.
- On the basis of application, the preimplantation genetic screening (PGS) technology market is segmented into embryo HLA typing for stem cell therapy, IVF prognosis, late onset genetic disorders, inherited genetic disease, and others.
Regional Insights: North America dominates the Global Preimplantation Genetic Screening (PGS) Technology Market
North America holds a dominant position in the preimplantation genetic screening (PGS) technology market. This can be attributed to the rising trend of late pregnancies in the region, resulting in increased demand for fertility treatments such as in vitro fertilization (IVF). The region's well-established healthcare infrastructure and accessibility to advanced reproductive technologies further bolster its prominence in the PGS technology sector.
Asia-Pacific is poised for substantial growth in the preimplantation genetic screening (PGS) technology market. The forecasted period of 2022 to 2029 anticipates the region's rapid expansion driven by multiple factors. The region is witnessing a surge in technological advancements and the adoption of preimplantation genetic testing (PGT) workflows. This growing adoption reflects the region's commitment to leveraging cutting-edge techniques for enhanced reproductive outcomes.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-preimplantation-genetic-screening-pgs-technology-market
The Prominent Key Players Operating in the Global Preimplantation Genetic Screening (PGS) Technology Market Include:
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- PerkinElmer, Inc. (U.S.)
- CooperSurgical, Inc. (U.S.)
- Beijing Genomics Institute (BGI) (China)
- Abbott (U.S.)
- Siemens (Germany)
- QIAGEN (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of global preimplantation genetic screening (PGS) technology market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Preimplantation Genetic Screening (PGS) Technology Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
